Group Executive Vice President, Advanced Endoscopic Technologies · CONMED Corp (CNMD)

John Kennedy

FY2020 is the first fiscal year CompBrief holds for John Kennedy as a named executive officer of CONMED; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,277,978

Salary $358,174Stock awards $488,450

5th of 5 named executive officers at Conmed by FY2020 total.

5 named officers on file for CONMED, FY2020

John Kennedy’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • CNMD’s disclosed peer group of 13 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how CONMED’s whole pay program stands against its peers

  • CONMED’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CNMD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 9, 2021 (DEF 14A).

Free

Get John Kennedy’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

John Kennedy compensation by year

CONMED Summary Compensation Table · the one fiscal year held
In US dollars, as CONMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$358,174
Bonus$0
Stock awards$488,450
Option awards$216,600
Non-equity incentive$171,127
Pension and deferred compensation$0
All other$43,627
Total$1,277,978

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: CONMED Corp DEF 14A filed April 9, 2021, accession 0001193125-21-111314, and prior-year filings. Open the filing on EDGAR.

How this page was built: the CONMED Corp filed document, accession 0001193125-21-111314. Every figure is read from that document and cited to the page and table it appears in. Filed April 9, 2021.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU5,000$560,000—
RSU3,750$420,000—
Option4,940—$39.87
Option10,000—$41.93
Option16,200—$59.96
Option7,600—$78.76
Option9,500—$97.69

Per the Outstanding Equity Awards at Fiscal Year-End table in CONMED Corp's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

CONMED’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Curt HartmanChair of the Board, President & Chief Executive Officer$6,461,620
Patrick BeyerPresident, CONMED International 7$2,186,455
Todd GarnerExecutive Vice President and Chief Financial Officer$2,034,904
Stanley PetersVice President & General Manager, U.S. Advanced Surgical$1,327,551
John Kennedy · this pageGroup Executive Vice President, Advanced Endoscopic Technologies$1,277,978

The full CONMED compensation record

free company brief

This page is one person within CONMED's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the CONMED proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are CONMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John Kennedy's compensation dossier · One-time report. No refunds.